For the quarter ending 2025-09-30, ABVC has $21,176,299 in assets. $6,683,592 in debts. $192,068 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 192,068 | 388,251 | ||
| Due from related parties | - | 1,422,405 | ||
| Restricted cash | 661,843 | 688,075 | ||
| Inventories | 11,460 | 11,460 | ||
| Due from related parties-Related Party | 2,694,743 | - | ||
| Short-term investments | 65,175 | 65,211 | ||
| Prepaid expense and other current assets | 447,280 | 194,999 | ||
| Total current assets | 4,072,569 | 2,770,401 | ||
| Property and equipment, gross | 15,440,055 | - | ||
| Less accumulated depreciation | 3,384,413 | - | ||
| Property and equipment, net | 12,055,642 | 8,215,366 | ||
| Operating lease right-of-use assets | 369,135 | 459,325 | ||
| Long-term investments | 2,745,194 | 2,837,922 | ||
| Prepayment for long-term investments | 1,124,842 | - | ||
| Prepayment for asset acquisition | 691,900 | 691,900 | ||
| Prepayment for long-term investments | - | 1,124,842 | ||
| Other non-current assets | 117,017 | 141,304 | ||
| Total assets | 21,176,299 | 16,241,060 | ||
| Short-term loans | 809,103 | 871,951 | ||
| Convertible notes payable third parties, net | - | 254,195 | ||
| Accrued expenses and other current liabilities | 3,991,414 | 4,290,964 | ||
| Due to related parties | - | 728,576 | ||
| Contract liabilities | 81,115 | 81,115 | ||
| Taxes payables | 6,170 | 23,521 | ||
| Operating lease liabilities | 199,335 | 282,192 | ||
| Due to related parties-Related Party | 1,201,592 | - | ||
| Convertible notes payable third parties, net | 68,791 | - | ||
| Convertible notes payable related party-Related Party | 150,000 | - | ||
| Total current liabilities | 6,507,520 | 6,532,514 | ||
| Tenant security deposit | 12,000 | 41,680 | ||
| Operating lease liability non-current | 164,072 | 177,133 | ||
| Total liabilities | 6,683,592 | 6,751,327 | ||
| Common stock, 0.001 par value, 100,000,000 authorized, 24,190,340 and 13,868,484 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 24,190 | 19,533 | ||
| Stock to be issued | 636,500 | 1,090,308 | ||
| Additional paid-in capital | 93,114,989 | 86,378,577 | ||
| Accumulated deficit | -73,295,417 | -72,048,904 | ||
| Accumulated other comprehensive income | 487,048 | 483,812 | ||
| Treasury stock | 8,909,691 | 8,909,691 | ||
| Total stockholders equity | 12,057,619 | 7,013,635 | ||
| Noncontrolling interest | 2,435,088 | 2,476,098 | ||
| Total equity | 14,492,707 | 9,489,733 | ||
| Total liabilities and equity | 21,176,299 | 16,241,060 | ||
ABVC BIOPHARMA, INC. (ABVC)
ABVC BIOPHARMA, INC. (ABVC)